IFNA1 and Autoimmunity: Future breakthroughs will likely depend on integrating these strategies to contextually amplify beneficial IFN responses while constraining pathological signaling, thereby transforming IFN biology into a controllable therapeutic axis across infection, autoimmunity, and cancer.